Huaxia Eye Hospital Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	3,864	3,774	3,745	3,130	3,007	2,472
Other Revenue	253.24	253.24	268.34	103.09	57.77	42.63
Revenue	4,117	4,027	4,013	3,233	3,064	2,515
Revenue Growth (YoY)	0.60%	0.34%	24.12%	5.51%	21.86%	2.37%
Cost of Revenue	2,340	2,259	2,055	1,687	1,661	1,461
Gross Profit	1,777	1,768	1,958	1,546	1,403	1,053
Selling, General & Admin	1,067	1,077	986.7	758.43	712.2	588.34
Research & Development	63.27	70.63	69.68	49.27	25.2	19.79
Other Operating Expenses	38.19	13.66	11.89	10.82	12.43	9.76
Operating Expenses	1,186	1,173	1,080	822.02	754.19	620.89
Operating Income	590.19	594.57	878.8	724.3	649.04	432.44
Interest Expense	-44.62	-45.13	-38.04	-38.36	-37.61	-6.22
Interest & Investment Income	65	87.6	99.96	19.2	10.47	3.4
Other Non Operating Income (Expenses)	22.02	-6.24	-124.11	-78.25	-5.97	-5.72
EBT Excluding Unusual Items	632.58	630.8	816.61	626.88	615.93	423.9
Impairment of Goodwill	-11.24	-11.24	-4.64	-	-	-
Gain (Loss) on Sale of Investments	-10.64	-5.09	11.02	6.51	-	-
Gain (Loss) on Sale of Assets	5.95	3.49	11.28	1.85	0.1	1.1
Asset Writedown	-1.21	-0.79	-1.51	-0.46	-1.88	-1.28
Other Unusual Items	-40.19	-54	21.55	18.83	-31.82	36.02
Pretax Income	575.24	563.17	854.31	653.61	582.33	459.74
Income Tax Expense	133.3	134.95	176.89	144.41	128.7	138.29
Earnings From Continuing Operations	441.95	428.22	677.42	509.2	453.63	321.45
Net Income to Company	441.95	428.22	677.42	509.2	453.63	321.45
Minority Interest in Earnings	-0.52	0.43	-11.49	4.62	1.29	13.01
Net Income	441.43	428.64	665.93	513.82	454.92	334.46
Net Income to Common	441.43	428.64	665.93	513.82	454.92	334.46
Net Income Growth	-16.62%	-35.63%	29.60%	12.95%	36.01%	53.59%
Shares Outstanding (Basic)	835	840	843	767	750	749
Shares Outstanding (Diluted)	835	840	843	767	750	749
Shares Change (YoY)	-0.74%	-0.29%	9.92%	2.28%	0.14%	0.85%
EPS (Basic)	0.53	0.51	0.79	0.67	0.61	0.45
EPS (Diluted)	0.53	0.51	0.79	0.67	0.61	0.45
EPS Growth	-16.00%	-35.44%	17.91%	10.43%	35.82%	52.30%
Free Cash Flow	624.98	540.71	512.81	534.68	624.38	427.34
Free Cash Flow Per Share	0.75	0.64	0.61	0.70	0.83	0.57
Dividend Per Share	0.310	0.220	0.110	0.187	-	-
Dividend Growth	181.82%	100.00%	-41.08%	-	-	-
Gross Margin	43.15%	43.90%	48.80%	47.83%	45.79%	41.89%
Operating Margin	14.34%	14.77%	21.90%	22.40%	21.18%	17.20%
Profit Margin	10.72%	10.64%	16.59%	15.89%	14.85%	13.30%
Free Cash Flow Margin	15.18%	13.43%	12.78%	16.54%	20.38%	16.99%
EBITDA	761.86	756.42	1,028	878.91	803.7	586.09
EBITDA Margin	18.51%	18.78%	25.60%	27.18%	26.23%	23.31%
D&A For EBITDA	171.67	161.85	148.75	154.61	154.66	153.65
EBIT	590.19	594.57	878.8	724.3	649.04	432.44
EBIT Margin	14.34%	14.77%	21.90%	22.40%	21.18%	17.20%
Effective Tax Rate	23.17%	23.96%	20.71%	22.10%	22.10%	30.08%
Revenue as Reported	4,117	4,027	4,013	3,233	3,064	2,515
Advertising Expenses	-	273.11	259.35	147.9	129.24	87.13

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.